We are live on ! Find out more
CCM

Camber Capital Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 8.19%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$3.07B
AUM Growth
-$181M
Cap. Flow
-$390M
Cap. Flow %
-12.7%
Top 10 Hldgs %
63.06%
Holding
43
New
2
Increased
11
Reduced
8
Closed
5

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$51.7M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$44.6M
3
GMED icon
Globus Medical
GMED
+$39.6M
4
WBA
Walgreens Boots Alliance
WBA
+$32.6M
5
HLF icon
Herbalife
HLF
+$26.2M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$80.7M
2
THC icon
Tenet Healthcare
THC
+$46.3M
3
SRPT icon
Sarepta Therapeutics
SRPT
+$45.1M
4
CNMD icon
CONMED
CNMD
+$33.8M
5
ZBH icon
Zimmer Biomet
ZBH
+$27.2M

Sector Composition

Rank Sector Weight
1 Healthcare 97.08%
2 Consumer Staples 1.66%
3 Consumer Discretionary 0.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UHS icon
1
Universal Health Services
UHS
$10.2B
$304M 9.89%
1,925,000
– –
THC icon
2
Tenet Healthcare
THC
$22.2B
$260M 8.48%
3,200,000
-650,000
-17% -$46.3M
VTRS icon
3
Viatris
VTRS
$20.8B
$225M 7.31%
22,500,000
– –
SNY icon
4
Sanofi
SNY
$107B
$216M 7.02%
4,000,000
-1,500,000
-27% -$80.7M
WBA
5
DELISTED
Walgreens Boots Alliance
WBA
$214M 6.96%
7,500,000
+1,000,000
+15% +$32.6M
MYGN icon
6
Myriad Genetics
MYGN
$476M
$154M 5.01%
6,635,000
-365,000
-5% -$7.97M
ZBH icon
7
Zimmer Biomet
ZBH
$18.8B
$153M 4.98%
1,050,000
-200,000
-16% -$27.2M
GSK icon
8
GSK
GSK
$107B
$146M 4.76%
4,100,000
-500,000
-11% -$17.9M
BAX icon
9
Baxter International
BAX
$12.8B
$137M 4.45%
3,000,000
– –
SEM
10
DELISTED
Select Medical
SEM
$129M 4.2%
7,516,800
-1,392,000
-16% -$21.6M
IONS icon
11
Ionis Pharmaceuticals
IONS
$8.93B
$103M 3.34%
2,500,000
+575,000
+30% +$22.1M
PTCT icon
12
PTC Therapeutics
PTCT
$6.18B
$102M 3.31%
2,500,000
– –
PRGO icon
13
Perrigo
PRGO
$1.44B
$84.9M 2.76%
2,500,000
– –
QTRX icon
14
Quanterix
QTRX
$159M
$77.2M 2.52%
3,425,000
– –
BKD icon
15
Brookdale Senior Living
BKD
$3.55B
$76M 2.47%
18,000,000
– –
XRAY icon
16
Dentsply Sirona
XRAY
$2.84B
$70.6M 2.3%
1,765,000
– –
MRTX
17
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$65M 2.12%
1,800,000
+400,000
+29% +$16.5M
TEVA icon
18
Teva Pharmaceuticals
TEVA
$40.4B
$64M 2.08%
8,500,000
+5,500,000
+183% +$44.6M
GMED icon
19
Globus Medical
GMED
$11.1B
$59.5M 1.94%
1,000,000
+695,000
+228% +$39.6M
MDT icon
20
Medtronic
MDT
$112B
$52.9M 1.72%
+600,000
New +$51.7M
SRPT icon
21
Sarepta Therapeutics
SRPT
$1.64B
$45.8M 1.49%
400,000
-350,000
-47% -$45.1M
ZIMV
22
DELISTED
ZimVie
ZIMV
$36.5M 1.19%
3,250,000
– –
HLF icon
23
Herbalife
HLF
$1.3B
$36.4M 1.19%
2,750,000
+1,925,000
+233% +$26.2M
REPL icon
24
Replimune Group
REPL
$455M
$36M 1.17%
1,550,000
+300,000
+24% +$5.86M
EXEL icon
25
Exelixis
EXEL
$13.9B
$29.6M 0.96%
1,550,000
– –
1
2

Similar funds

PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
NRD
Nebula Research & Development New York $1.17B AUM 15.19% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return
CCP
Camelot Capital Partners Laguna Beach, California $686M AUM 163.55% 1-Year Est. Return

Camber Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Camber Capital Management held 43 positions worth $3.07B, down 5.6% from $3.25B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Camber Capital Management withdrew a net $390M in Q2 2023, closing 5 positions and reducing 8 holdings. Its most notable exit was CONMED, an estimated $33.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 89% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, Camber Capital Management opened a new position in Medtronic worth $52.9M.

  • Camber Capital Management's largest Q2 2023 buy was Medtronic: 600,000 shares worth $52.9M.
  • Camber Capital Management added most to Teva Pharmaceuticals in Q2 2023, an estimated $44.6M increase.
  • Camber Capital Management's biggest Q2 2023 reduction was Sanofi, cutting an estimated $80.7M.
  • Camber Capital Management fully exited CONMED in Q2 2023, selling an estimated $33.8M.
  • Camber Capital Management's ten largest holdings make up 63% of its $3.07B portfolio in Q2 2023.
  • Camber Capital Management opened 2 new positions and closed 5 in Q2 2023.
  • Camber Capital Management's portfolio value fell 5.6% quarter-over-quarter to $3.07B.

Based on Camber Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.